First Amended and Restated Exclusive License Agreement For Tostrex® Between STRAKAN INTERNATIONAL LIMITED And Cellegy Pharmaceuticals, Inc. ConfidentialExclusive License Agreement • March 31st, 2006 • Cellegy Pharmaceuticals Inc • Pharmaceutical preparations • Pennsylvania
THIS FIRST AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT (this "Agreement") is made and entered into as of January 16, 2006 (the “Agreement Date”), by and between Cellegy Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at 1800 Byberry Road, Building 13, Huntingdon Valley, PA, 19006-3525 USA ("Cellegy"), and Strakan International Limited, a company organized and existing under the laws of Bermuda with a branch office at Buckholm Mill, Galashiels, TD1 2HB, UK ("Licensee”").
FIRST AMENDED AND RESTATED EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT FOR RECTOGESIC® Between STRAKAN INTERNATIONAL LIMITED And Cellegy Pharmaceuticals, Inc. ConfidentialExclusive License and Distribution Agreement • March 31st, 2006 • Cellegy Pharmaceuticals Inc • Pharmaceutical preparations • California
ProStrakan Group plc (“Group”) hereby unconditionally guarantees and undertakes to Cellegy that Licensee will duly and punctually observe and perform all the undertakings, covenants and obligations of Licensee under this Agreement (including the payment of any damages becoming due to Cellegy as a result of any breach by Licensee of such undertakings, covenants and obligations) and under any agreements between the Parties (or any of them) which are expressly supplemental to this Agreement or which this Agreement requires to be executed (the “Obligations”) to the intent that if Licensee shall fail for whatever reason so to observe and perform any Obligations, Group shall be liable to perform the same in all respects as if Group was the party principally bound thereby in place of Licensee on demand from Cellegy.
CELLEGY PHARMACEUTICALS, INC. STOCK OPTION AGREEMENTStock Option Agreement • March 31st, 2006 • Cellegy Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Stock Option Agreement (this "Agreement") is made and entered into as of the date of grant set forth below (the "Date of Grant") by and between Cellegy Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and the participant named below ("Participant"). Capitalized terms not defined herein shall have the meaning ascribed to them in the Company's 2005 Equity Incentive Plan, as amended (the "2005 Plan").
